Asensus Surgical, Inc. (ASXC) Misses Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021
November 3, 2021 4:05 PM EDTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, today announced its operating and financial results for the third quarter 2021.
Recent Highlights
Record quarter for procedures performed using Senhance® Surgical Systems, growing 47% over the prior year Four Senhance Surgical Programs recently initiated, three in Japan and one in Russia Received FDA 510(k) clearance for expanded capabilities of the Intelligent Surgical... More